查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1653142

2025 年基于 NGS 的 RNA定序全球市场报告

NGS-Based RNA-Sequencing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年基于 NGS 的 RNA定序市场将呈指数级增长。到 2029 年，这一数字将成长至 104 亿美元，复合年增长率为 25.2%。预测期内的成长归因于临床诊断、国际合作研究、伦理和监管框架、农业和环境研究以及绿色基因组学。预测期内的主要趋势包括单细胞 RNA 定序（scRNA-seq）、空间转录组学、表观转录组学、多组体学整合和永续农业。

精准医疗的扩张正在推动基于NGS的RNA定序市场的成长。精准医疗可协助医疗保健提供者制定客製化的治疗计划，并根据对患者病情的基因了解做出决策。精准医疗在治疗癌症等严重方面受到越来越多的关注。基于 NGS 的 RNA定序有助于识别疾病的根本原因并推荐特定的精准治疗方法。例如，根据美国非营利组织个人化医疗联盟（PMC）2023年2月的报告，2021年新核准的新分子药物（NME）中有35%是个人化药物。 2022 年有 12 种新药核准，过去八年一直占新药认证的四分之一以上，而十年前这一比例还不到 10%。随着精准医疗的需求不断成长，基于NGS的RNA定序的需求也将持续成长。

不断扩张的製药业预计将推动基于 NGS 的 RNA定序市场的未来成长。製药业包括公共和私人组织对药品和医药产品的发现、开发和生产。基于NGS的RNA定序正被用于透过深入分析基因表现、识别潜在药物标靶、评估药物反应和阐明疾病机制来更深入地了解分子过程，从而增强基因表现和开发。例如，2024年9月，美国ABA治疗服务供应商Cross River Therapy发布的数据显示，美国製药业的销售额为5,500亿美元，2021年美国在药物上的支出为5,769亿美元。预计到 2025 年将从 6,050 亿美元增加到 6,350 亿美元。因此，製药业的成长正在推动基于NGS的RNA定序市场的扩张。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第 4 章市场：宏观经济情景，包括利率、通膨、地缘政治、新冠疫情以及復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球基于NGS的RNA定序PESTEL分析（政治、社会、技术、环境、法律、驱动因素、限制因素）
  • 最终用途产业分析
  • 全球基于 NGS 的 RNA定序市场：成长率分析
  • 全球基于 NGS 的 RNA定序市场表现：规模与成长，2019 年至 2024 年
  • 全球基于 NGS 的 RNA定序市场预测：规模与成长，2024-2029 年，2034 年预测
  • 全球基于 NGS 的 RNA定序总目标市场 (TAM)

第六章 市场细分

  • 全球基于 NGS 的 RNA定序市场（依产品与服务、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 样品製备产品
  • 定序平台和耗材
  • 定序服务
  • 分析、储存和管理资料
  • 全球基于 NGS 的 RNA定序市场（按技术、性能和预测），2019 年至 2024 年，2024 年至 2029 年，2034 年
  • 合成定序
  • 离子半导体定序
  • 单分子即时定序
  • 奈米孔定序
  • 全球基于 NGS 的 RNA定序市场（按应用、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 表达谱分析
  • 小RNA定序
  • 从头转录组组装
  • 突变调用和转录组表观遗传学
  • 全球基于 NGS 的 RNA定序市场（按最终用户、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 研究与学术
  • 医院和诊所
  • 製药和生物技术公司
  • 其他最终用户
  • 全球基于 NGS 的 RNA定序市场：样品製备产品细分、类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • RNA萃取试剂套件
  • 文库製备试剂套件
  • 逆转录试剂套件
  • 品管试剂
  • 全球基于 NGS 的 RNA定序市场：按定序平台和耗材细分，按类型、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 定序设备
  • 定序耗材
  • 全球基于 NGS 的 RNA定序市场：定序服务细分、类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 合约排序服务
  • 自订文库製备服务
  • 咨询和实验设计服务
  • 全球基于 NGS 的 RNA定序市场：资料分析、储存和管理细分市场，按类型、实际值和预测，2019-2024 年、2024-2029 年、2034 年
  • 生物资讯软体
  • 资料分析服务
  • 云端基础的资料储存解决方案
  • 资料管理平台

第七章 区域和国家分析

  • 全球基于 NGS 的 RNA定序市场：按地区、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 全球基于 NGS 的 RNA定序市场：按国家/地区划分、绩效和预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第 17 章 德国市场

第 18 章 法国市场

第 19 章：义大利市场

第 20 章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第 25 章：加拿大市场

第26章 南美洲市场

第 27 章：巴西市场

第28章 中东市场

第 29 章：非洲市场

第 30 章竞争格局与公司概况

  • 基于 NGS 的 RNA定序市场：竞争格局
  • 基于 NGS 的 RNA定序市场：公司简介
    • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Oxford Nanopore Technologies Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • BGI Group Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • QIAGEN NV
  • PerkinElmer Inc.
  • Eurofins Scientific SE
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • Hamilton Company
  • Takara Bio Inc.
  • Tecan Trading AG
  • GENEWIZ Inc.
  • Novogene Corporation
  • Macrogen Inc.
  • Zymo Research Corp.
  • Lexogen GmbH
  • Partek Incorporated
  • GATC Biotech AG

第 32 章 全球市场竞争基准化分析与仪表板

第33章 重大併购

第 34 章 近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029 年基于 NGS 的 RNA定序市场：提供新机会的国家
  • 基于 NGS 的 RNA定序市场 2029：细分市场将带来新机会
  • 基于 NGS 的 RNA定序市场 2029：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第 36 章 附录

简介目录
Product Code: r21852

NGS-based RNA-sequencing is a technique employed to identify and quantify the amount of ribonucleic acid (RNA) present in a biological sample at a specific moment, utilizing next-generation sequencing (NGS). Next-generation sequencing, characterized by massively parallel sequencing technology, offers exceptionally high throughput, scalability, and speed, allowing for the determination of nucleotide sequences in whole genomes or specific DNA/RNA segments.

The primary products and services associated with NGS-based RNA sequencing include sample preparation products, sequencing platforms and consumables, sequencing services, and data analysis, storage, & management. Sample preparation products facilitate the adherence of DNA or RNA to the sequencing flowcell, enabling sample identification. The sample preparation process involves converting nucleic acid mixtures from biological samples into various libraries, preparing them for NGS technologies. Technologies involved in NGS encompass sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, and nanopore sequencing. These sequencing methods find application in expression profiling analysis, small RNA sequencing, de novo transcriptome assembly, variant calling, and transcriptome epigenetics. NGS-based RNA-sequencing is utilized by a range of end users, including research & academia, hospitals & clinics, pharmaceutical & biotechnology companies, and other entities in the scientific community.

The NGS-based RNA sequencing market research report is one of a series of new reports from The Business Research Company that provides NGS-based RNA sequencing market statistics, including NGS-based RNA sequencing industry global market size, regional shares, competitors with a NGS-based RNA sequencing market share, detailed NGS-based RNA sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the NGS-based RNA sequencing industry. This NGS-based RNA sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The NGS-based RNA-sequencing market size has grown exponentially in recent years. It will grow from $3.41 billion in 2024 to $4.23 billion in 2025 at a compound annual growth rate (CAGR) of 24.2%. The growth in the historic period can be attributed to genomic research initiatives, reduction in sequencing costs, drug discovery and development, personalized medicine, increasing ngs adoption.

The NGS-based RNA-sequencing market size is expected to see exponential growth in the next few years. It will grow to $10.4 billion in 2029 at a compound annual growth rate (CAGR) of 25.2%. The growth in the forecast period can be attributed to clinical diagnostics, global collaborations, ethical and regulatory frameworks, agricultural and environmental research, green genomics. Major trends in the forecast period include single-cell rna-sequencing (scrna-seq), spatial transcriptomics, epitranscriptomics, multi-omics integration, sustainable agriculture.

The expansion of precision medicine is propelling the growth of the NGS-based RNA sequencing market. Precision medicine assists healthcare providers in creating tailored treatment plans and making decisions based on a genetic understanding of the patient's condition. There is an increasing focus on precision medicines for addressing serious diseases such as cancer. NGS-based RNA sequencing is instrumental in identifying the underlying causes of diseases and recommending specific precision treatments. For example, in February 2023, a report from the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, indicated that personalized medicines represented 35% of newly approved New Molecular Entities (NMEs) in 2021. With 12 new approvals in 2022, they have consistently accounted for at least a quarter of new drug approvals over the past eight years, marking a substantial rise from less than 10% a decade ago. As the demand for precision medicines continues to grow, so too will the demand for NGS-based RNA sequencing.

The expanding pharmaceutical industry is anticipated to drive the growth of the NGS-based RNA sequencing market in the future. The pharmaceutical industry encompasses the discovery, development, and production of drugs and medicines by both public and private organizations. NGS-based RNA sequencing is utilized within this sector to conduct thorough analyses of gene expression, identify potential drug targets, evaluate drug responses, and comprehend disease mechanisms, thereby enhancing drug discovery and development through a better understanding of molecular processes. For instance, in September 2024, statistics published by Cross River Therapy, a US-based provider of ABA therapy services, revealed that the U.S. pharmaceutical industry generated $550 billion in revenue, with Americans spending $576.9 billion on medications in 2021. Projected spending is expected to rise to between $605 billion and $635 billion by 2025. Consequently, the growth of the pharmaceutical industry is propelling the expansion of the NGS-based RNA sequencing market.

A notable trend in the NGS-based RNA sequencing market is the formation of strategic partnerships. Companies are increasingly engaging in partnerships with NGS-based RNA sequencing firms to enter new markets and leverage collective resources. For instance, in May 2022, The Biomedical Advanced Research and Development Authority (BARDA) partnered with multiple industry and academic collaborators to enhance diagnostic capabilities for respiratory RNA viruses. Such strategic partnerships contribute to bolstering the capacity to respond swiftly to public health emergencies and advance diagnostic capabilities.

Major companies in the NGS-based RNA-sequencing market are concentrating on innovative products to meet the growing demand for RNA sequencing. One such innovation is the development of ultra-fast RNA methods for molecular testing and life science research applications, offering exceptionally rapid RNA sequencing or analysis. In March 2022, Quantabio launched the sparQ RNA-Seq HMR Kit, an ultra-fast RNA library preparation tool designed for precision oncology applications. This kit enables the generation of high-quality NGS sequencer-ready libraries from intact or degraded samples in a single day.

In October 2022, Illumina Inc., a US-based company specializing in DNA sequencing and array-based technology, announced a collaboration with GenoScreen. This partnership seeks to enhance access to genomic testing for multidrug-resistant tuberculosis (MDR-TB), facilitating faster and more effective detection of drug resistance to aid in the global fight against TB, particularly in countries severely affected by the disease. GenoScreen is a France-based company focused on sequencing, genotyping, and bioinformatics.

Major companies operating in the ngs-based rna-sequencing market include Illumina Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Ltd., Agilent Technologies Inc., BGI Group, QIAGEN N.V., PerkinElmer Inc., Eurofins Scientific SE, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Hamilton Company, Takara Bio Inc., Tecan Trading AG, GENEWIZ Inc., Novogene Corporation, Macrogen Inc., Zymo Research Corp., Lexogen GmbH, Partek Incorporated, GATC Biotech AG, Becton, Dickinson and Company, Genohub LLC, BaseClear B.V., Genewave SAS, Otogenetics Corporation, SeqLL LLC, GenXPro GmbH, Genotypic Technology Pvt. Ltd.

North America was the largest region in the NGS-based RNA sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in NGS-based RNA sequencing market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the NGS-based RNA sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The NGS-based RNA-sequencing market includes revenues earned by ribosomal RNA (rRNA), transfer RNA (tRNA), long ncRNA and many smaller ncRNAs such as microRNA. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

NGS-Based RNA-Sequencing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ngs-based rna-sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ngs-based rna-sequencing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ngs-based rna-sequencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product And Service: Sample Preparation Products; Sequencing Platforms and Consumables; Sequencing Services; Data Analysis, Storage, and Management
  • 2) By Technology: Sequencing by Synthesis; Ion Semiconductor Sequencing; Single-molecule Real-time Sequencing; Nanopore Sequencing
  • 3) By Application: Expression Profiling Analysis; Small RNA Sequencing; De Novo Transcriptome Assembly; Variant Calling and Transcriptome Epigenetics
  • 4) By End User: Research & Academia; Hospitals & Clinics; Pharmaceutical & Biotechnology Companies; Other End Users
  • Subsegments:
  • 1) By Sample Preparation Products: RNA Extraction Kits; Library Preparation Kits; Reverse Transcription Kits; Quality Control Reagents
  • 2) By Sequencing Platforms And Consumables: Sequencing Instruments; Sequencing Consumables
  • 3) By Sequencing Services: Contract Sequencing Services; Custom Library Preparation Services; Consultation And Experimental Design Services
  • 4) By Data Analysis, Storage, And Management: Bioinformatics Software; Data Analysis Services; Cloud-Based Data Storage Solutions; Data Management Platforms
  • Companies Mentioned: Illumina Inc.; Thermo Fisher Scientific Inc.; Oxford Nanopore Technologies Ltd.; Agilent Technologies Inc.; BGI Group
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. NGS-Based RNA-Sequencing Market Characteristics

3. NGS-Based RNA-Sequencing Market Trends And Strategies

4. NGS-Based RNA-Sequencing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global NGS-Based RNA-Sequencing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global NGS-Based RNA-Sequencing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global NGS-Based RNA-Sequencing Market Growth Rate Analysis
  • 5.4. Global NGS-Based RNA-Sequencing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global NGS-Based RNA-Sequencing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global NGS-Based RNA-Sequencing Total Addressable Market (TAM)

6. NGS-Based RNA-Sequencing Market Segmentation

  • 6.1. Global NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sample Preparation Products
  • Sequencing Platforms and Consumables
  • Sequencing Services
  • Data Analysis, Storage, and Management
  • 6.2. Global NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Single-molecule Real-time Sequencing
  • Nanopore Sequencing
  • 6.3. Global NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Expression Profiling Analysis
  • Small RNA Sequencing
  • De Novo Transcriptome Assembly
  • Variant Calling and Transcriptome Epigenetics
  • 6.4. Global NGS-Based RNA-Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Research & Academia
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Other End Users
  • 6.5. Global NGS-Based RNA-Sequencing Market, Sub-Segmentation Of Sample Preparation Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • RNA Extraction Kits
  • Library Preparation Kits
  • Reverse Transcription Kits
  • Quality Control Reagents
  • 6.6. Global NGS-Based RNA-Sequencing Market, Sub-Segmentation Of Sequencing Platforms And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sequencing Instruments
  • Sequencing Consumables
  • 6.7. Global NGS-Based RNA-Sequencing Market, Sub-Segmentation Of Sequencing Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Contract Sequencing Services
  • Custom Library Preparation Services
  • Consultation And Experimental Design Services
  • 6.8. Global NGS-Based RNA-Sequencing Market, Sub-Segmentation Of Data Analysis, Storage, And Management, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bioinformatics Software
  • Data Analysis Services
  • Cloud-Based Data Storage Solutions
  • Data Management Platforms

7. NGS-Based RNA-Sequencing Market Regional And Country Analysis

  • 7.1. Global NGS-Based RNA-Sequencing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global NGS-Based RNA-Sequencing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific NGS-Based RNA-Sequencing Market

  • 8.1. Asia-Pacific NGS-Based RNA-Sequencing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China NGS-Based RNA-Sequencing Market

  • 9.1. China NGS-Based RNA-Sequencing Market Overview
  • 9.2. China NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India NGS-Based RNA-Sequencing Market

  • 10.1. India NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan NGS-Based RNA-Sequencing Market

  • 11.1. Japan NGS-Based RNA-Sequencing Market Overview
  • 11.2. Japan NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia NGS-Based RNA-Sequencing Market

  • 12.1. Australia NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia NGS-Based RNA-Sequencing Market

  • 13.1. Indonesia NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea NGS-Based RNA-Sequencing Market

  • 14.1. South Korea NGS-Based RNA-Sequencing Market Overview
  • 14.2. South Korea NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe NGS-Based RNA-Sequencing Market

  • 15.1. Western Europe NGS-Based RNA-Sequencing Market Overview
  • 15.2. Western Europe NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK NGS-Based RNA-Sequencing Market

  • 16.1. UK NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany NGS-Based RNA-Sequencing Market

  • 17.1. Germany NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France NGS-Based RNA-Sequencing Market

  • 18.1. France NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy NGS-Based RNA-Sequencing Market

  • 19.1. Italy NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain NGS-Based RNA-Sequencing Market

  • 20.1. Spain NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe NGS-Based RNA-Sequencing Market

  • 21.1. Eastern Europe NGS-Based RNA-Sequencing Market Overview
  • 21.2. Eastern Europe NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia NGS-Based RNA-Sequencing Market

  • 22.1. Russia NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America NGS-Based RNA-Sequencing Market

  • 23.1. North America NGS-Based RNA-Sequencing Market Overview
  • 23.2. North America NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA NGS-Based RNA-Sequencing Market

  • 24.1. USA NGS-Based RNA-Sequencing Market Overview
  • 24.2. USA NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada NGS-Based RNA-Sequencing Market

  • 25.1. Canada NGS-Based RNA-Sequencing Market Overview
  • 25.2. Canada NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America NGS-Based RNA-Sequencing Market

  • 26.1. South America NGS-Based RNA-Sequencing Market Overview
  • 26.2. South America NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil NGS-Based RNA-Sequencing Market

  • 27.1. Brazil NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East NGS-Based RNA-Sequencing Market

  • 28.1. Middle East NGS-Based RNA-Sequencing Market Overview
  • 28.2. Middle East NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa NGS-Based RNA-Sequencing Market

  • 29.1. Africa NGS-Based RNA-Sequencing Market Overview
  • 29.2. Africa NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. NGS-Based RNA-Sequencing Market Competitive Landscape And Company Profiles

  • 30.1. NGS-Based RNA-Sequencing Market Competitive Landscape
  • 30.2. NGS-Based RNA-Sequencing Market Company Profiles
    • 30.2.1. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Oxford Nanopore Technologies Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. BGI Group Overview, Products and Services, Strategy and Financial Analysis

31. NGS-Based RNA-Sequencing Market Other Major And Innovative Companies

  • 31.1. QIAGEN N.V.
  • 31.2. PerkinElmer Inc.
  • 31.3. Eurofins Scientific SE
  • 31.4. Bio-Rad Laboratories Inc.
  • 31.5. F. Hoffmann-La Roche Ltd.
  • 31.6. Hamilton Company
  • 31.7. Takara Bio Inc.
  • 31.8. Tecan Trading AG
  • 31.9. GENEWIZ Inc.
  • 31.10. Novogene Corporation
  • 31.11. Macrogen Inc.
  • 31.12. Zymo Research Corp.
  • 31.13. Lexogen GmbH
  • 31.14. Partek Incorporated
  • 31.15. GATC Biotech AG

32. Global NGS-Based RNA-Sequencing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The NGS-Based RNA-Sequencing Market

34. Recent Developments In The NGS-Based RNA-Sequencing Market

35. NGS-Based RNA-Sequencing Market High Potential Countries, Segments and Strategies

  • 35.1 NGS-Based RNA-Sequencing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 NGS-Based RNA-Sequencing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 NGS-Based RNA-Sequencing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer